ID   AK1A1_RAT               Reviewed;         325 AA.
AC   P51635;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=Aldo-keto reductase family 1 member A1;
DE            EC=1.1.1.2 {ECO:0000269|PubMed:22820017, ECO:0000269|PubMed:4463942, ECO:0000269|PubMed:8500767};
DE            EC=1.1.1.372 {ECO:0000269|PubMed:22820017};
DE            EC=1.1.1.54 {ECO:0000269|PubMed:25152401};
DE   AltName: Full=3-DG-reducing enzyme {ECO:0000303|PubMed:8500767};
DE   AltName: Full=Alcohol dehydrogenase [NADP(+)];
DE   AltName: Full=Aldehyde reductase {ECO:0000303|PubMed:7827091};
DE   AltName: Full=Glucuronate reductase {ECO:0000303|PubMed:22820017};
DE            EC=1.1.1.19 {ECO:0000269|PubMed:22820017};
DE   AltName: Full=Glucuronolactone reductase {ECO:0000303|PubMed:22820017};
DE            EC=1.1.1.20 {ECO:0000269|PubMed:22820017};
DE   AltName: Full=S-nitroso-CoA reductase {ECO:0000305};
DE            Short=ScorR {ECO:0000305};
DE            EC=1.6.-.- {ECO:0000250|UniProtKB:P14550};
GN   Name=Akr1a1; Synonyms=Alr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, TISSUE SPECIFICITY,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Kidney, and Liver;
RX   PubMed=8500767; DOI=10.1016/0378-1119(93)90728-l;
RA   Takahashi M., Fujii J., Teshima T., Suzuki K., Shiba T., Taniguchi N.;
RT   "Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde
RT   reductase in rat liver established by amino acid sequencing and cDNA
RT   expression.";
RL   Gene 127:249-253(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 14-30; 62-77; 81-97; 135-145 AND 146-157, GLYCATION AT
RP   LYS-23; LYS-68; LYS-85; LYS-141 AND LYS-153, AND ABSENCE OF GLYCATION AT
RP   LYS-13; LYS-30; LYS-34; LYS-61; LYS-80; LYS-97; LYS-127; LYS-134; LYS-145;
RP   LYS-157; LYS-240; LYS-257; LYS-263; LYS-287; LYS-294 AND LYS-308.
RX   PubMed=7827091; DOI=10.1021/bi00004a038;
RA   Takahashi M., Lu Y.B., Myint T., Fujii J., Wada Y., Taniguchi N.;
RT   "In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing
RT   enzyme: identification of glycation sites.";
RL   Biochemistry 34:1433-1438(1995).
RN   [4]
RP   PROTEIN SEQUENCE OF 204-218; 222-240; 270-287 AND 313-325, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [5]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=4463942; DOI=10.1042/bj1390205;
RA   Beedle A.S., Rees H.H., Goodwin T.W.;
RT   "Some properties and a suggested reclassification of mevaldate reductase.";
RL   Biochem. J. 139:205-209(1974).
RN   [6]
RP   ACETYLATION AT THR-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Lubec G., Chen W.-Q.;
RL   Submitted (FEB-2007) to UniProtKB.
RN   [7]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY,
RP   AND FUNCTION.
RX   PubMed=22820017; DOI=10.1016/j.bbagen.2012.07.003;
RA   Takahashi M., Miyata S., Fujii J., Inai Y., Ueyama S., Araki M., Soga T.,
RA   Fujinawa R., Nishitani C., Ariki S., Shimizu T., Abe T., Ihara Y.,
RA   Nishikimi M., Kozutsumi Y., Taniguchi N., Kuroki Y.;
RT   "In vivo role of aldehyde reductase.";
RL   Biochim. Biophys. Acta 1820:1787-1796(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [9]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=25152401; DOI=10.1016/j.bbrc.2014.08.072;
RA   Kurahashi T., Kwon M., Homma T., Saito Y., Lee J., Takahashi M., Yamada K.,
RA   Miyata S., Fujii J.;
RT   "Reductive detoxification of acrolein as a potential role for aldehyde
RT   reductase (AKR1A) in mammals.";
RL   Biochem. Biophys. Res. Commun. 452:136-141(2014).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of a wide variety of
CC       carbonyl-containing compounds to their corresponding alcohols. Displays
CC       enzymatic activity towards endogenous metabolites such as aromatic and
CC       aliphatic aldehydes, ketones, monosaccharides and bile acids
CC       (PubMed:22820017, PubMed:25152401). Plays an important role in ascorbic
CC       acid biosynthesis by catalyzing the reduction of D-glucuronic acid and
CC       D-glucurono-gamma-lactone (PubMed:22820017). Functions as a
CC       detoxifiying enzyme by reducing a range of toxic aldehydes. Reduces
CC       methylglyoxal and 3-deoxyglucosone, which are present at elevated
CC       levels under hyperglycemic conditions and are cytotoxic
CC       (PubMed:25152401, PubMed:8500767). Involved also in the detoxification
CC       of lipid-derived aldehydes like acrolein (PubMed:25152401). Plays a
CC       role in the activation of procarcinogens, such as polycyclic aromatic
CC       hydrocarbon trans-dihydrodiols, and in the metabolism of various
CC       xenobiotics and drugs (By similarity). Also acts as an inhibitor of
CC       protein S-nitrosylation by mediating degradation of S-nitroso-coenzyme
CC       A (S-nitroso-CoA), a cofactor required to S-nitrosylate proteins (By
CC       similarity). S-nitroso-CoA reductase activity is involved in
CC       reprogramming intermediary metabolism in renal proximal tubules,
CC       notably by inhibiting protein S-nitrosylation of isoform 2 of PKM
CC       (PKM2) (By similarity). Also acts as a S-nitroso-glutathione reductase
CC       by catalyzing the NADPH-dependent reduction of S-nitrosoglutathione (By
CC       similarity). Displays no reductase activity towards retinoids (By
CC       similarity). {ECO:0000250|UniProtKB:P14550,
CC       ECO:0000250|UniProtKB:P50578, ECO:0000269|PubMed:22820017,
CC       ECO:0000269|PubMed:25152401, ECO:0000269|PubMed:8500767}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a primary alcohol + NADP(+) = an aldehyde + H(+) + NADPH;
CC         Xref=Rhea:RHEA:15937, ChEBI:CHEBI:15378, ChEBI:CHEBI:15734,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.2;
CC         Evidence={ECO:0000269|PubMed:8500767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-gulonate + NADP(+) = aldehydo-D-glucuronate + H(+) + NADPH;
CC         Xref=Rhea:RHEA:14909, ChEBI:CHEBI:13115, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:142686;
CC         EC=1.1.1.19; Evidence={ECO:0000269|PubMed:22820017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-gulono-1,4-lactone + NADP(+) = D-glucurono-3,6-lactone +
CC         H(+) + NADPH; Xref=Rhea:RHEA:18925, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17587, ChEBI:CHEBI:18268, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.1.1.20;
CC         Evidence={ECO:0000269|PubMed:22820017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=allyl alcohol + NADP(+) = acrolein + H(+) + NADPH;
CC         Xref=Rhea:RHEA:12168, ChEBI:CHEBI:15368, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16605, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.54;
CC         Evidence={ECO:0000269|PubMed:25152401};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycerol + NADP(+) = D-glyceraldehyde + H(+) + NADPH;
CC         Xref=Rhea:RHEA:23592, ChEBI:CHEBI:15378, ChEBI:CHEBI:17378,
CC         ChEBI:CHEBI:17754, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.372; Evidence={ECO:0000269|PubMed:22820017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycerol + NADP(+) = H(+) + L-glyceraldehyde + NADPH;
CC         Xref=Rhea:RHEA:38111, ChEBI:CHEBI:15378, ChEBI:CHEBI:17754,
CC         ChEBI:CHEBI:27975, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.372; Evidence={ECO:0000269|PubMed:22820017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hydroxyacetone + NADP(+) = H(+) + methylglyoxal + NADPH;
CC         Xref=Rhea:RHEA:27986, ChEBI:CHEBI:15378, ChEBI:CHEBI:17158,
CC         ChEBI:CHEBI:27957, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000269|PubMed:22820017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-deoxyfructose + NADP(+) = 3-deoxyglucosone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:58668, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:60777, ChEBI:CHEBI:142685;
CC         Evidence={ECO:0000269|PubMed:22820017, ECO:0000269|PubMed:8500767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-mevalonate + NADP(+) = (R)-mevaldate + H(+) + NADPH;
CC         Xref=Rhea:RHEA:20193, ChEBI:CHEBI:15378, ChEBI:CHEBI:36464,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:195523;
CC         Evidence={ECO:0000269|PubMed:4463942};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + pyridine 3-methanol = H(+) + NADPH + pyridine-3-
CC         carbaldehyde; Xref=Rhea:RHEA:58776, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28345, ChEBI:CHEBI:45213, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; Evidence={ECO:0000269|PubMed:8500767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + S-nitroso-CoA = NADP(+) + sulfinamide-CoA;
CC         Xref=Rhea:RHEA:78375, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:145546, ChEBI:CHEBI:145548;
CC         Evidence={ECO:0000250|UniProtKB:P14550};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:78376;
CC         Evidence={ECO:0000250|UniProtKB:P14550};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + S-nitrosoglutathione = NADP(+) + S-
CC         (hydroxysulfenamide)glutathione; Xref=Rhea:RHEA:63500,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:145544, ChEBI:CHEBI:229723;
CC         Evidence={ECO:0000250|UniProtKB:Q9JII6};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.9 mM for D,L glyceraldehyde {ECO:0000269|PubMed:22820017};
CC         KM=1.8 mM for D-glucuronic acid {ECO:0000269|PubMed:22820017};
CC         KM=0.31 mM for methylglyoxal {ECO:0000269|PubMed:22820017};
CC         KM=0.63 mM for 3-deoxyglucosone {ECO:0000269|PubMed:22820017};
CC         KM=11 mM for D-glucurono-gamma-lactone {ECO:0000269|PubMed:22820017};
CC         KM=2.4 mM for acrolein {ECO:0000269|PubMed:25152401};
CC         KM=0.260 mM for mevaldate {ECO:0000269|PubMed:4463942};
CC         Note=kcat is 3.0 sec(-1) for D,L glyceraldehyde as substrate
CC         (PubMed:22820017). kcat is 3.0 sec(-1) for methylglyoxal as substrate
CC         (PubMed:22820017). kcat is 3.4 sec(-1) for 3-deoxyglucosone as
CC         substrate (PubMed:22820017). kcat is 3.1 sec(-1) for D-glucuronic
CC         acid as substrate (PubMed:22820017). kcat is 3.7 sec(-1) for D-
CC         glucurono-gamma-lactone acid as substrate (PubMed:22820017).
CC         {ECO:0000269|PubMed:22820017};
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P50578}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q9JII6}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:Q9JII6}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:8500767}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D10854; BAA01627.1; -; mRNA.
DR   EMBL; BC059133; AAH59133.1; -; mRNA.
DR   PIR; JN0629; JN0629.
DR   RefSeq; NP_112262.1; NM_031000.3.
DR   AlphaFoldDB; P51635; -.
DR   SMR; P51635; -.
DR   IntAct; P51635; 1.
DR   STRING; 10116.ENSRNOP00000023072; -.
DR   BindingDB; P51635; -.
DR   ChEMBL; CHEMBL3871; -.
DR   DrugCentral; P51635; -.
DR   GlyCosmos; P51635; 5 sites, No reported glycans.
DR   iPTMnet; P51635; -.
DR   PhosphoSitePlus; P51635; -.
DR   SwissPalm; P51635; -.
DR   jPOST; P51635; -.
DR   PaxDb; 10116-ENSRNOP00000023072; -.
DR   Ensembl; ENSRNOT00000023072.6; ENSRNOP00000023072.3; ENSRNOG00000016727.6.
DR   Ensembl; ENSRNOT00055022714; ENSRNOP00055018448; ENSRNOG00055013242.
DR   Ensembl; ENSRNOT00060050456; ENSRNOP00060042012; ENSRNOG00060029038.
DR   Ensembl; ENSRNOT00065027773; ENSRNOP00065021894; ENSRNOG00065016659.
DR   GeneID; 78959; -.
DR   KEGG; rno:78959; -.
DR   UCSC; RGD:68346; rat.
DR   AGR; RGD:68346; -.
DR   CTD; 10327; -.
DR   RGD; 68346; Akr1a1.
DR   eggNOG; KOG1577; Eukaryota.
DR   GeneTree; ENSGT00940000156539; -.
DR   HOGENOM; CLU_023205_0_0_1; -.
DR   InParanoid; P51635; -.
DR   OMA; MVNQIFL; -.
DR   OrthoDB; 890110at2759; -.
DR   PhylomeDB; P51635; -.
DR   TreeFam; TF106492; -.
DR   BRENDA; 1.1.1.2; 5301.
DR   Reactome; R-RNO-156590; Glutathione conjugation.
DR   Reactome; R-RNO-5661270; Formation of xylulose-5-phosphate.
DR   SABIO-RK; P51635; -.
DR   PRO; PR:P51635; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016727; Expressed in adult mammalian kidney and 19 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0004032; F:aldose reductase (NADPH) activity; ISO:RGD.
DR   GO; GO:0047655; F:allyl-alcohol dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047941; F:glucuronolactone reductase activity; IDA:UniProtKB.
DR   GO; GO:0047956; F:glycerol dehydrogenase (NADP+) activity; IEA:RHEA.
DR   GO; GO:0047939; F:L-glucuronate reductase activity; IDA:UniProtKB.
DR   GO; GO:1990002; F:methylglyoxal reductase (NADPH) (acetol producing) activity; IEA:RHEA.
DR   GO; GO:0080007; F:S-nitrosoglutathione reductase (NADH) activity; ISO:RGD.
DR   GO; GO:0160163; F:S-nitrosoglutathione reductase (NADPH) activity; IEA:RHEA.
DR   GO; GO:0046185; P:aldehyde catabolic process; ISO:RGD.
DR   GO; GO:0110095; P:cellular detoxification of aldehyde; IDA:UniProtKB.
DR   GO; GO:0042840; P:D-glucuronate catabolic process; IMP:UniProtKB.
DR   GO; GO:0044597; P:daunorubicin metabolic process; ISO:RGD.
DR   GO; GO:0044598; P:doxorubicin metabolic process; ISO:RGD.
DR   GO; GO:0019640; P:glucuronate catabolic process to xylulose 5-phosphate; ISO:RGD.
DR   GO; GO:0019853; P:L-ascorbic acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   CDD; cd19106; AKR_AKR1A1-4; 1.
DR   Gene3D; 3.20.20.100; NADP-dependent oxidoreductase domain; 1.
DR   InterPro; IPR020471; AKR.
DR   InterPro; IPR044481; AKR1A.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR   PANTHER; PTHR11732:SF544; ALDO-KETO REDUCTASE FAMILY 1 MEMBER A1; 1.
DR   PANTHER; PTHR11732; ALDO/KETO REDUCTASE; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; NAD(P)-linked oxidoreductase; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Cytoplasm; Direct protein sequencing;
KW   Glycation; Glycoprotein; Lipid metabolism; Membrane; NADP; Oxidoreductase;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.6"
FT   CHAIN           2..325
FT                   /note="Aldo-keto reductase family 1 member A1"
FT                   /id="PRO_0000124620"
FT   ACT_SITE        50
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P14550"
FT   BINDING         11..20
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:O60218"
FT   BINDING         21
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         22
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         45
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         162
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         163
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         211
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         213
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         215
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         216
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         263
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         264
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         265
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         266
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         269
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         272
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   BINDING         273
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P50578"
FT   SITE            13
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            30
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            34
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            61
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            80
FT                   /note="Lowers pKa of active site Tyr"
FT                   /evidence="ECO:0000250|UniProtKB:P14550"
FT   SITE            80
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            97
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            127
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            134
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            145
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            157
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            240
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            257
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            263
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            287
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            294
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   SITE            308
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0000269|Ref.6"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14550"
FT   MOD_RES         127
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JII6"
FT   MOD_RES         127
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JII6"
FT   MOD_RES         145
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JII6"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14550"
FT   CARBOHYD        23
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   CARBOHYD        68
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   CARBOHYD        85
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   CARBOHYD        141
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7827091"
FT   CARBOHYD        153
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7827091"
SQ   SEQUENCE   325 AA;  36506 MW;  F95573B7411884DA CRC64;
     MTASSVLLHT GQKMPLIGLG TWKSEPGQVK AAIKYALSVG YRHIDCASVY GNETEIGEAL
     KESVGAGKAV PREELFVTSK LWNTKHHPED VEPAVRKTLA DLQLEYLDLY LMHWPYAFER
     GDNPFPKNAD GTVKYDSTHY KETWKALEAL VAKGLVKALG LSNFSSRQID DVLSVASVRP
     AVLQVECHPY LAQNELIAHC QARGLEVTAY SPLGSSDRAW RHPDEPVLLE EPVVLALAEK
     HGRSPAQILL RWQVQRKVIC IPKSITPSRI LQNIQVFDFT FSPEEMKQLD ALNKNWRYIV
     PMITVDGKRV PRDAGHPLYP FNDPY
//
